🔎 Trials Near Me

Home › Colorectal Cancer › Utah

Colorectal Cancer clinical trials in Utah

35 studies for Colorectal Cancer are looking for participants at sites in Utah.

Cities in Utah

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer

  • Huntsman Cancer Institute - University of Utah, Salt Lake City
  • START Mountain Region, West Valley City
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT07659795

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

  • START Mountain Region, West Valley City
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT06270706

A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

  • Huntsman Cancer Institute, University of Utah, Salt Lake City
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT07458347

A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

  • START Mountain Region, West Valley City
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT06004245

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

  • Huntsman Cancer Institute, Salt Lake City
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 10, 2026 · NCT07020221

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

  • START Mountain Region, LLC, West Valley City
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 10, 2026 · NCT07503808

A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors

  • START Mountain Region, West Valley City
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07318805

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

  • Clinical Study Site, Salt Lake City
  • Clinical Study Site, Salt Lake City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07228832

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

  • START Mountain Region, West Valley City
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06400472

Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors

  • Start Center for Cancer Research - Mountain Region, West Valley City
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT05856981

A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies

  • University of Utah - Huntsman Cancer Institute, Salt Lake City
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07542704

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

  • Huntsman Cancer Institute/University of Utah, Salt Lake City
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT05673148

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

  • Utah Cancer Specialists, Salt Lake City
  • University of Utah Health Huntsman Cancer Hospital, Salt Lake City
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 2, 2026 · NCT03526835

A Study of MGC026 in Participants With Advanced Solid Tumors

  • START Mountain Region, West Valley City
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT06242470

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

  • Huntsman Cancer Institute, University of Utah, Salt Lake City
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 26, 2026 · NCT06330064

JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration

  • Huntsman Cancer Institute, Salt Lake City
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 26, 2026 · NCT06973564

A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers

  • Huntsman Cancer Institute, Salt Lake City
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT07544589

Colonoscopy vs Stool Testing for Older Adults With Colon Polyps

  • University of Utah, Salt Lake City
  • Intermountain Health, Sandy City
Recruiting
Ages 65 to 82 · All sexes · Updated Oct 2, 2026 · NCT05612347

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

  • ALX Center 4, West Valley City
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07085091

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

  • Huntsman Cancer Institute, University of Utah, Salt Lake City
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06445062

An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis

  • Huntsman Cancer Institute/University of Utah, Salt Lake City
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT06557733

A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

  • START Mountain Region, Salt Lake City
  • South Texas Accelerated Research Therapeutics Mountain Region, West Valley City
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 22, 2026 · NCT06131840

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

  • Huntsman Cancer Institute, University of Utah, Salt Lake City
  • START Mountain Region, LLC., West Valley City
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 15, 2026 · NCT06657144

A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors

  • START Mountain Region, West Valley City
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 6, 2026 · NCT07300150

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

  • Huntsman Cancer Institute, Salt Lake City
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 2, 2026 · NCT06917079

A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies

  • START Mountain Region, West Valley City
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated May 28, 2026 · NCT07223047

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

  • Huntsman Cancer Institute, Salt Lake City
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated May 15, 2026 · NCT05379985

A Study of MGC028 in Participants With Advanced Solid Tumors

  • South Texas Accelerated Research Therapeutics (START) Mountain Region, West Valley City
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Apr 27, 2026 · NCT06723236

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

  • START Center for Cancer Care - Mountain Region, Salt Lake City
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Mar 27, 2026 · NCT06395519

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

  • START Mountain Region, West Valley City
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Feb 18, 2026 · NCT07030257

Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

  • START, Mountain Region, West Valley City
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Feb 17, 2026 · NCT07145255

ColoCare Study - Colorectal Cancer Cohort

  • Huntsman Cancer Institute, Salt Lake City
RecruitingObservational study
Ages 18 to 89 · All sexes · Updated Jun 13, 2025 · NCT02328677

Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays

  • Utah Cancer Specialists, Salt Lake City
RecruitingObservational study
Ages 18 and older · All sexes · Updated May 6, 2025 · NCT05234177

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.